Sign in
NeurosciencebioRxiv
Preprint

Mini-heterochromatin domains constrain the cis-regulatory impact of SVA transposons in human brain development and disease

Vivien HorváthiD, Raquel GarzaiD, Marie E. JönssoniD, Pia Annette JohanssoniD, Anita AdamiiD, Georgia ChristoforidouiD, Ofelia KarlssoniD, Laura Castilla‐VallmanyaiD, Patricia GerdesiD, Ninoslav PandiloskiiD, Christopher H. DouseiD, Johan JakobssoniD

Abstract

SVA retrotransposons remain active in humans and contribute to individual genetic variation. Polymorphic SVA alleles harbor gene-regulatory potential and can cause genetic disease. However, how SVA insertions are controlled and functionally impact human disease is unknown. Here, we dissect the epigenetic regulation and influence of SVAs in cellular models of X-linked dystonia-parkinsonism (XDP), a neurodegenerative disorder caused by an SVA insertion at the TAF1 locus. We demonstrate that the KRAB zinc finger protein ZNF91 establishes H3K9me3 and DNA methylation over SVAs, including polymorphic alleles, in human neural progenitor cells. The resulting mini-heterochromatin domains attenuate the cis-regulatory impact of SVAs. This is critical for XDP pathology; removal of local heterochromatin severely aggravates the XDP molecular phenotype, resulting in increased TAF1 intron retention and reduced expression. Our results provide unique mechanistic insights into how human polymorphic transposon insertions are recognized, and their regulatory impact constrained by an innate epigenetic defense system.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISRosenkrantz '23Zhang '25Aneichyk '18Barnada '22D’Ignazio '22Prakash '25
77% semantic matchNeuroscience
Jimi L. Rosenkrantz, Sanaz Raghib, J. Elias Brandorff+5 more·bioRxiv·Oct 20, 2023